In 2023, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recommended ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory ...

Despite the Centers for Disease Control and Prevention's recommendations, vaccine rates against COVID-19, RSV, and the flu ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

Particularly if you tend not to have vaccine side effects, getting routine shots in one go may be a convenient option.

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you ...

The vaccine is recommended for use only in the run-up to RSV season. It's time for RSV, flu, and COVID shots, and the CDC has ...

RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...

Clinician-scientists analyzed samples from patients' airways and blood, finding distinct changes in children with severe cases of RSV, including an increase in the number of natural killer (NK) cells ...